Paper41968952
Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association.
Pürerfellner H and 4 others. Europace, 2026. Cited by 1 paper, by iCite.
Cite this record
ConductScience Library. Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association. Papers, record 41968952. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41968952
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pulsed field ablation: from technological breakthrough to structured clinical implementation-the role of the European Heart Rhythm Association.
- PubMed
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Atrial Fibrillation | Major topic |
| Cardiology | Major topic |
| Irreversible Electroporation Therapy | Major topic |
| Humans | |
| Diffusion of Innovation | |
| Europe | |
| Societies, Medical | |
| Treatment Outcome |
Source PubMed
References14
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 39298665 | 2024 updated European Heart Rhythm Association core curriculum for physicians and allied professionals: a statement of the European Heart Rhythm Association of the European Society of Cardiology. | Europace | 2024 | https://conductscience.org/library/papers/39298665 | PubMed |
| 2 | 40888735 | Real-world experience with the pentaspline pulsed field ablation system: one-year outcomes of the FARADISE registry. | Europace | 2025 | https://conductscience.org/library/papers/40888735 | PubMed |
| 3 | 40845172 | Incidence of laboratory-defined severe intravascular haemolysis across commercially available pulsed field ablation technologies for atrial fibrillation. | Europace | 2025 | https://conductscience.org/library/papers/40845172 | PubMed |
| 4 | 40802569 | EHRA perspective on the digital data revolution in arrhythmia management: insights from the association's annual summit. | Europace | 2025 | https://conductscience.org/library/papers/40802569 | PubMed |
| 5 | 41248987 | Characterization of sedation strategies in real-world use of pulsed field ablation Sub-analysis of the EU-PORIA registry. | Europace | 2025 | https://conductscience.org/library/papers/41248987 | PubMed |
| 6 | 41690439 | 2026 HRS/EHRA scientific statement on pulsed field ablation for cardiac arrhythmias. | Heart Rhythm | 2026 | https://conductscience.org/library/papers/41690439 | PubMed |
| 7 | 38385529 | Long-term outcomes of the pentaspline pulsed-field ablation catheter for the treatment of paroxysmal atrial fibrillation: results of the prospective, multicentre FARA-Freedom Study. | Europace | 2024 | https://conductscience.org/library/papers/38385529 | PubMed |
| 8 | 41363248 | Pulsed field ablation for atrial fibrillation ablation: a European Heart Rhythm Association survey. | Europace | 2025 | https://conductscience.org/library/papers/41363248 | PubMed |
| 9 | 41125244 | Anterior mitral isthmus line using pulsed-field ablation with the pentaspline catheter or radiofrequency ablation: procedural characteristics, safety, and mid-term outcomes. | Europace | 2025 | https://conductscience.org/library/papers/41125244 | PubMed |
| 10 | 40697128 | Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders. | Europace | 2025 | https://conductscience.org/library/papers/40697128 | PubMed |
| 11 | 38848447 | State-of-the-art pulsed field ablation for cardiac arrhythmias: ongoing evolution and future perspective. | Europace | 2024 | https://conductscience.org/library/papers/38848447 | PubMed |
| 12 | 39077807 | Same-day discharge vs. overnight stay following catheter ablation for atrial fibrillation: a comprehensive review and meta-analysis by the European Heart Rhythm Association Health Economics Committee. | Europace | 2024 | https://conductscience.org/library/papers/39077807 | PubMed |
| 13 | 41968953 | Pulsed field ablation for the interventional treatment of atrial fibrillation: a scientific statement of the European Heart Rhythm Association of the European Society of Cardiology, the Heart Rhythm Society, the Asia Pacific Heart Rhythm Society, the Latin American Heart Rhythm Society, and the Canadian Heart Rhythm Society. | Europace | 2026 | https://conductscience.org/library/papers/41968953 | PubMed |
| 14 | 41437309 | Controversy: pulsed field ablation is the standard technique for all the candidates for atrial fibrillation ablation. | Europace | 2025 | https://conductscience.org/library/papers/41437309 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42739524 | Phenotype-Guided Management of Atrial Fibrillation in Heart Failure: From Rate Control to Catheter Ablation. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739524 |
Source PubMed
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41968952
GET https://conductscience.org/api/papers/v1/41968952/authors